Cary Adams on World Cancer Day and COVID-19’s Impact on Cancer Care


CancerNetwork® spoke with the CEO of the Union for International Cancer Control to learn more about their efforts in oncology amidst the COVID-19 pandemic, and the work they are doing on World Cancer Day.

For World Cancer Day, the Union for International Cancer Control (UICC) is focusing its efforts on the nurses, doctors, researchers, volunteers, advocates, and other caregivers in oncology who are fighting the coronavirus disease 2019 (COVID-19) pandemic. The UICC’s “I Am and I Will” theme allows them to shine a light on those caregivers and the stories they tell.

“COVID-19 has impacted cancer control globally and the response by the cancer community has been extraordinary, heroic even,” said Dr. Cary Adams, CEO of UICC, in a press release. “This year, more than ever, it is appropriate that we celebrate their achievements on World Cancer Day. Let us all aim in 2021 to refocus our collective efforts on the long-term challenges that cancer poses to every country in the world. We must prevent more, diagnose earlier, and ensure that all people living with cancer have access to the quality treatment they need.”

In an interview with CancerNetwork®, Adams discussed research that UICC conducted, and the continuing efforts needed to combat COVID-19 in cancer care.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.


Adaptations and innovations in cancer care through COVID-19 and beyond. News release. Union for International Cancer Control. Published January 19, 2021. Accessed February 4, 2021.

Related Videos
Cancer vaccines are a “cross-cutting approach” that may be applicable across several cancer types, according to Catherine J. Wu, MD.
mRNA may be a potential modality for developing cancer-based vaccines, according to Catherine J. Wu, MD.
Analyzing the KRAS mutation across various cancer types may be a worthwhile target when using a cancer vaccine or immunotherapy, says Catherine J. Wu, MD.
The AACR Health Disparities Report highlights the changes needed to achieve health equity for patients with cancer.
Robert A. Winn, MD, gives insight into how institutions and community practices can improve access to cancer care.
In the October edition of Snap Recap, we review the latest FDA news and the vote from the last ODAC meeting.
In this September edition of Snap Recap, we share our highlights from Prostate Cancer Awareness Month, news in the breast cancer space, and the latest FDA updates.
Implementing tax benefits for manufacturers who produce chemotherapy drugs may be one solution to increase drug production in the United States, according to Lucio N. Gordan, MD.
Lucio N. Gordan, MD, describes how his practice deals with increasing costs of limited chemotherapy agents to ensure that patients with cancer continue to receive treatment.
Related Content